Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term cotrimoxazole prophylaxis for recurrent urinary tract infection in children
ACTRN12608000470392Phase 3Completed
- Sponsor
- The Children's Hospital at Westmead
- Start
- Nov 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) comparing Low-dose cotrimoxazole with Matched placebo (2 arms). Primary endpoint: Repeat symptomatic microbiologically proven urinary tract infection. Started Nov 1998; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ACTRN12608000470392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000470392.